« Back
Home /
Radotinib

Radotinib

Item no.	TMO-T2328-1ml
Manufacturer	TargetMol
CASRN	926037-48-1
Amount	1ml
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Smiles	Cc1c(cc(cc1)C(=O)Nc1cc(cc(c1)n1cc(nc1)C)C(F)(F)F)Nc1nccc(n1)c1nccnc1
ECLASS 5.1	30220300
ECLASS 6.1	30220300
ECLASS 8.0	32160605
ECLASS 9.0	32160605
ECLASS 10.0.1	32160490
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	IY-5511 , Supect
Similar products	926037-48-1
Available
Short Description	Radotinib, and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors
Shipping	cool pack
Storage	-20°
Target names or alias	IY-5511 , Supect
Molecular Weight	530, 5
Pathway	Angiogenesis\|\|\|Tyrosine Kinase/Adaptors\|\|\|Cytoskeletal Signaling
Target	Bcr-Abl

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1ml

available

Delivery expected until 8/2/2024